SANA · Sana Biotechnology, Inc.
Substantial doubt about the company's ability to continue as a going concern.
“Management has determined that our present capital resources may not be sufficient to fund our planned operations for at least one year from the date of this Quarterly Report, and there is substantial doubt as to our ability to continue as a going concern.”View the 10-Q filed Aug 10, 2026
Positioning
Sep 18, 2026 · 27 days to expiryChain
Click any strike for greeks, breakeven and the calculator| Calls | Puts | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| OI | Vol | IV | Δ | Last | Strike | Last | Δ | IV | Vol | OI |
| 102 | 2 | — | — | $1.45 | $0.11 | -0.114 | 166.7% | 1 | 27 | |
| 1.2k | 66 | 100% | 0.226 | $0.20 | $1.25 | -0.902 | 66.6% | 3 | 0 | |
| 22 | 100 | 163.5% | 0.106 | $0.03 | — | — | — | — | 0 | |
About this data
Each contract's last price, volume, greeks, implied volatility and open interest belongs to the snapshot session shown in its details; unknown means the provider omitted the timestamp. This chain has mixed snapshot sessions · Aug 6, 2026–Aug 21, 2026; 1 unknown. Cross-contract positioning totals are shown only when every returned row has the same known session. Bid and ask are not included on this plan.
In-the-money strikes are tinted, deepening toward the money, and the bar beside each open-interest figure scales to the heaviest strike shown.